Mirna Therapeutics, Inc. and Collaborators Publish New Data on In Vivo Delivery of microRNA Mimics

AUSTIN, Texas--(BUSINESS WIRE)--Mirna Therapeutics, Inc. announced today the publication of new results in the journal Molecular Therapy demonstrating how a neutral lipid emulsion facilitates the systemic delivery of tumor suppressor miRNA mimics and reduces the tumor burden in the lungs of mice.

MORE ON THIS TOPIC